Monkeypox Virus (MPXV) Infection: A Review


Cite item

Full Text

Abstract

Monkeypox is a viral disease; its outbreak was recently declared a global emergency by the World Health Organization. For the first time, a monkeypox virus (MPXV)-infected patient was found in India. Various researchers back-to-back tried to find the solution to this health emergency just after COVID-19. In this review, we discuss the current outbreak status of India, its transmission, virulence factors, symptoms, treatment, and the preventive guidelines generated by the Indian Health Ministry. We found that monkeypox virus (MPXV) disease is different from smallpox, and the age group between 30-40 years old is more prone to MPXV disease. We also found that, besides homosexuals, gays, bisexuals, and non-vegetarians, it also affects normal straight men and women who have no history of travel. Close contact should be avoided from rats, monkeys and sick people who are affected by monkeypox. To date, there are no monkeypox drugs, but Tecovirimat is more effective than other drugs that are used for other viral diseases like smallpox. Therefore, we need to develop an effective antiviral agent against the virulence factor of MXPV.

About the authors

Rosy Kumari

Department of Genetics, Maharshi Dayanand University

Email: info@benthamscience.net

Pooja Arya

Department of Psychology, University of Patanjal

Email: info@benthamscience.net

Surya Yadav

Department of Yoga, University of Patanjali

Email: info@benthamscience.net

Ratish Mishra

Department of Genetics, Maharshi Dayanand University

Author for correspondence.
Email: info@benthamscience.net

Jaya Parkash Yadav

Department of Genetics, Maharshi Dayanand University

Email: info@benthamscience.net

References

  1. Guarner J, del Rio C, Malani PN. Monkeypox in 2022-what clinicians need to know. JAMA 2022; 328(2): 139-40. doi: 10.1001/jama.2022.10802 PMID: 35696257
  2. WHO. Monkeypox Available from: https://www.who.int/multi-media/details/monkeypox--what-you-need-to-know (Accessed on:July 25, 2022)
  3. Breman JG. Kalisa-Ruti, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ 1980; 58(2): 165-82. PMID: 6249508
  4. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis 2022; 16(2): e0010141. doi: 10.1371/journal.pntd.0010141 PMID: 35148313
  5. Esteban DJ, Hutchinson AP. Genes in the terminal regions of orthopoxvirus genomes experience adaptive molecular evolution. BMC Genomics 2011; 12(1): 261. doi: 10.1186/1471-2164-12-261 PMID: 21605412
  6. Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK. Monkeypox: A review of clinical features, diagnosis, and treatment. Cureus 2022; 14(7): e26756. doi: 10.7759/cureus.26756 PMID: 35967174
  7. Alkhalil A, Hammamieh R, Hardick J, Ichou MA, Jett M, Ibrahim S. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions. Virol J 2010; 7(1): 173. doi: 10.1186/1743-422X-7-173 PMID: 20667104
  8. Vivancos R, Anderson C, Blomquist P, et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Euro Surveill 2022; 27(22): 2200422. doi: 10.2807/1560-7917.ES.2022.27.22.2200422 PMID: 35656834
  9. Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution. Viruses 2020; 12(11): 1257. doi: 10.3390/v12111257 PMID: 33167496
  10. Monkeypox. World Health Organization. Available from: https://www.who.int/news-room/questions-and-answers/item/monkeypox (Accessed on:July 25, 2022).
  11. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med 2022; 387(8): 679-91. doi: 10.1056/NEJMoa2207323 PMID: 35866746
  12. Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis 2017; 216(7): 824-8. doi: 10.1093/infdis/jix260 PMID: 29029147
  13. Bragazzi NL, Kong JD, Mahroum N, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review. J Med Virol 2023; 95(1): e27931. doi: 10.1002/jmv.27931 PMID: 35692117
  14. Cho CT, Wenner HA. Monkeypox virus. Bacteriol Rev 1973; 37(1): 1-18. doi: 10.1128/br.37.1.1-18.1973 PMID: 4349404
  15. Pickup DJ. Extracellular virions: The advance guard of poxvirus infections. PLoS Pathog 2015; 11(7): e1004904. doi: 10.1371/journal.ppat.1004904 PMID: 26135739
  16. Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med 2022; 387(19): 1783-93. doi: 10.1056/NEJMra2208860 PMID: 36286263
  17. Kugelman JR, Johnston SC, Mulembakani PM, et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis 2014; 20(2): 232-9. doi: 10.3201/eid2002.130118 PMID: 24457084
  18. Esposito JJ, Knight JC. Orthopoxvirus DNA: A comparison of restriction profiles and maps. Virology 1985; 143(1): 230-51. doi: 10.1016/0042-6822(85)90111-4 PMID: 2998003
  19. Rahman MJ, Haller SL, Stoian AMM, Li J, Brennan G, Rothenburg S. LINE-1 retrotransposons facilitate horizontal gene transfer into poxviruses. eLife 2022; 11: e63327. doi: 10.7554/eLife.63327 PMID: 36069678
  20. Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: A re-emergent threat to humans. Virol Sin 2022; 37(4): 477-82. doi: 10.1016/j.virs.2022.07.006 PMID: 35820590
  21. Mukherjee AG, Wanjari UR, Kannampuzha S, et al. The pathophysiological and immunological background of the monkeypox virus infection: An update. J Med Virol 2023; 95(1): e28206. doi: 10.1002/jmv.28206 PMID: 36217803
  22. Chen N, Li G, Liszewski MK, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005; 340(1): 46-63. doi: 10.1016/j.virol.2005.05.030 PMID: 16023693
  23. Forsyth KS, Roy NH, Peauroi E, et al. Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading. PLoS Pathog 2020; 16(8): e1008685. doi: 10.1371/journal.ppat.1008685 PMID: 32745153
  24. Song H, Josleyn N, Janosko K, et al. Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLoS One 2013; 8(10): e77804. doi: 10.1371/journal.pone.0077804 PMID: 24147080
  25. Lopera JG, Falendysz EA, Rocke TE, Osorio JE. Attenuation of monkeypox virus by deletion of genomic regions. Virology 2015; 475: 129-38. doi: 10.1016/j.virol.2014.11.009 PMID: 25462353
  26. Unterholzner L, Sumner RP, Baran M, et al. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 2011; 7(9): e1002247. doi: 10.1371/journal.ppat.1002247 PMID: 21931555
  27. Fernández de Marco MM, Alejo A, Hudson P, Damon IK, Alcami A. The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. FASEB J 2010; 24(5): 1479-88. doi: 10.1096/fj.09-144733 PMID: 20019241
  28. Huang J, Huang Q, Zhou X, et al. The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J Biol Chem 2004; 279(52): 54110-6. doi: 10.1074/jbc.M410583200 PMID: 15496420
  29. Scutts SR, Ember SW, Ren H, et al. DNA-PK is targeted by multiple vaccinia virus proteins to inhibit DNA sensing. Cell Rep 2018; 25(7): 1953-1965.e4. doi: 10.1016/j.celrep.2018.10.034 PMID: 30428360
  30. Hudson PN, Self J, Weiss S, et al. Elucidating the role of the complement control protein in monkeypox pathogenicity. PLoS One 2012; 7(4): e35086. doi: 10.1371/journal.pone.0035086 PMID: 22496894
  31. Huggins J, Goff A, Hensley L, et al. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother 2009; 53(6): 2620-5. doi: 10.1128/AAC.00021-09 PMID: 19349521
  32. Kieser Q, Noyce RS, Shenouda M, Lin YCJ, Evans DH. Cytoplasmic factories, virus assembly, and DNA replication kinetics collectively constrain the formation of poxvirus recombinants. PLoS One 2020; 15(1): e0228028. doi: 10.1371/journal.pone.0228028 PMID: 31945138
  33. Begum JPS, Ngangom L, Semwal P, Painuli S, Sharma R, Gupta A. Emergence of monkeypox: A worldwide public health crisis. Hum Cell 2023; 36(3): 877-93. doi: 10.1007/s13577-023-00870-1 PMID: 36749539
  34. Niu L, Liang D, Ling Q, et al. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments. Front Immunol 2023; 14: 1132250. doi: 10.3389/fimmu.2023.1132250 PMID: 37026012
  35. Rampogu S, Kim Y, Kim SW, Lee KW. An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics. Front Cell Infect Microbiol 2023; 13: 1076251. doi: 10.3389/fcimb.2023.1076251 PMID: 36844409
  36. Sklenovská N. Monkeypox virus. In: Animal-origin viral zoonoses. Singapore: Springer 2020; pp. 39-68. doi: 10.1007/978-981-15-2651-0_2
  37. Bose S, Aggarwal S, Singh DV, Acharya N. Extracellular vesicles: An emerging platform in gram-positive bacteria. Microb Cell 2020; 7(12): 312-22. doi: 10.15698/mic2020.12.737 PMID: 33335921
  38. Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: A comprehensive review of transmission, pathogenesis, and manifestation. Cureus 2022; 14(7): e26531. doi: 10.7759/cureus.26531 PMID: 35928395
  39. Kmiec D, Kirchhoff F. Monkeypox: a new threat? Int J Mol Sci 2022; 23(14): 7866. doi: 10.3390/ijms23147866 PMID: 35887214
  40. Moss B. Poxvirus DNA replication. Cold Spring Harb Perspect Biol 2013; 5(9): a010199. doi: 10.1101/cshperspect.a010199 PMID: 23838441
  41. Wang Y, Kang W, Yang W, Zhang J, Li D, Zheng H. Structure of African swine fever virus and associated molecular mechanisms underlying infection and immunosuppression: A review. Front Immunol 2021; 12: 715582. doi: 10.3389/fimmu.2021.715582 PMID: 34552586
  42. van Heuvel Y, Schatz S, Rosengarten JF, Stitz J. Infectious RNA: Human immunodeficiency virus (HIV) biology, therapeutic intervention, and the quest for a vaccine. Toxins 2022; 14(2): 138. doi: 10.3390/toxins14020138 PMID: 35202165
  43. Erez N, Achdout H, Milrot E, et al. Diagnosis of imported monkeypox, Israel, 2018. Emerg Infect Dis 2019; 25(5): 980-3. doi: 10.3201/eid2505.190076 PMID: 30848724
  44. Luo Q, Han J. Preparedness for a monkeypox outbreak. Infect Med 2022; 1(2): 124-34. doi: 10.1016/j.imj.2022.07.001
  45. Nalca A, Livingston VA, Garza NL, et al. Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus. PLoS One 2010; 5(9): e12880. doi: 10.1371/journal.pone.0012880 PMID: 20862223
  46. Falendysz EA, Lopera JG, Doty JB, et al. Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.). PLoS Negl Trop Dis 2017; 11(8): e0005809. doi: 10.1371/journal.pntd.0005809 PMID: 28827792
  47. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis 2014; 58(2): 260-7. doi: 10.1093/cid/cit703 PMID: 24158414
  48. Mileto D, Riva A, Cutrera M, et al. New challenges in human monkeypox outside Africa: A review and case report from Italy. Travel Med Infect Dis 2022; 49: 102386. doi: 10.1016/j.tmaid.2022.102386 PMID: 35738529
  49. Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs 2022; 82(9): 957-63. doi: 10.1007/s40265-022-01742-y PMID: 35763248
  50. Stittelaar KJ, Neyts J, Naesens L, et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 2006; 439(7077): 745-8. doi: 10.1038/nature04295 PMID: 16341204
  51. Smith SK, Self J, Weiss S, et al. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus. J Virol 2011; 85(17): 9176-87. doi: 10.1128/JVI.02173-10 PMID: 21697474
  52. Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A, Hensley LE. In vitro inhibition of monkeypox virus production and spread by Interferon-β. Virol J 2012; 9(1): 5. doi: 10.1186/1743-422X-9-5 PMID: 22225589
  53. Zovi A, Ferrara F, Langella R, Vitiello A. Prarmacological agents with antiviral activity against monkeypox infection. Int J Mol Sci 2022; 23(24): 15941. doi: 10.3390/ijms232415941 PMID: 36555584
  54. Dirchi R. India reports its 4th monkeypox case; WHO declares global emergency. Available from: https://www.livemint.com (Accessed on:July 25, 2022).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers